Omada Health
OMDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 |
| % Growth | 38.3% | 37.7% | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 60.6% | 57% | 48% |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | -22.3% | -47.5% | -71.7% |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | -27.8% | -55% | -81.3% |
| EPS Diluted | -0.85 | -1.21 | -1.3 |
| % Growth | 29.8% | 6.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 |